Understanding how certain drugs can activate a key receptor in diabetes treatment differently.
Structural definition of biased agonism in the nuclear receptor PPAR gamma.
This study is looking at new types of diabetes medications that work differently with a key receptor in the body, aiming to find better treatments that help manage type II diabetes with fewer side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Montana NIH-funded |
| Lab location | 1 site (Missoula, United States) |
| Project ID | NIH-10901844 on NIH RePORTER |
What this research studies
This research investigates how specific drugs, known as biased agonists, interact with the PPARγ receptor, which is crucial for treating type II diabetes. By examining how these drugs activate the receptor differently than traditional treatments, the study aims to uncover mechanisms that could lead to more effective therapies with fewer side effects. The approach involves detailed structural analysis and understanding the interactions between the receptor and various coactivators. This could ultimately help in developing new medications that maintain the benefits of existing treatments while minimizing adverse effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type II diabetes who are currently managing their condition with medication.
Not a fit: Patients who do not have type II diabetes or those who are not currently on any diabetes medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of safer and more effective diabetes medications.
How similar studies have performed: Previous research has shown promise in understanding biased agonism in other contexts, suggesting potential for success in this area as well.
Where this research is happening
Missoula, United States
- University of Montana — Missoula, United States (Active)
Researchers
- Principal investigator: Hughes, Travis Shane — University of Montana
- Study coordinator: Hughes, Travis Shane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.